 | Up a level |
2022
Ben Khaled, Najib, Seidensticker, Max, Ricke, Jens, Mayerle, Julia, Oehrle, Bettina, Roessler, Daniel, Teupser, Daniel, Ehmer, Ursula, Bitzer, Michael 
ORCID: 0000-0002-4463-8263, Waldschmidt, Dirk, Fuchs, Martin, Reuken, Philipp A., Lange, Christian M., Wege, Henning, Kandulski, Arne, Dechene, Alexander, Venerito, Marino, Berres, Marie-Luise, Luedde, Tom ORCID: 0000-0002-6288-8821, Kubisch, Ilja, Reiter, Florian P. and De Toni, Enrico N.
(2022).
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol.
Future Oncol., 18 (12).
S. 1423 - 1436.
LONDON:
FUTURE MEDICINE LTD.
ISSN 1744-8301
2015
Schulze, Kornelius, Weismueller, Tobias J., Bubenheim, Michael, Huebener, Peter ORCID: 0000-0001-7558-7625, Zenouzi, Roman, Lenzen, Henrike, Rupp, Christian, Gotthardt, Daniel, de Leuw, Philipp, Teufel, Andreas, Zimmer, Vincent ORCID: 0000-0002-6298-4717, Reiter, Florian P., Rust, Christian, Tharun, Lars, Quaas, Alexander, Weidemann, Soern A., Lammert, Frank, Sarrazin, Christoph, Manns, Michael P., Lohse, Ansgar W. and Schramm, Christoph ORCID: 0000-0002-4264-1928
(2015).
Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing Cholangitis.
PLoS One, 10 (10).
SAN FRANCISCO:
PUBLIC LIBRARY SCIENCE.
ISSN 1932-6203